• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[苯丙醇胺控释混悬液在健康志愿者中的生物利用度]

[Bioavailability of a controlled-release suspension of phenylpropanolamine in healthy volunteers].

作者信息

Chen Q C, Chen W L, Dai Y Q, Ge G Q, Lin D C

机构信息

Zhongshan Hospital, Shanghai Medical University.

出版信息

Yao Xue Xue Bao. 1992;27(4):299-302.

PMID:1442046
Abstract

A high-performance liquid chromatographic analysis of phenylpropanolamine (PPA) in human plasma is presented. Using direct UV detection the method is sufficiently sensitive to 25 ng/ml for PPA. Single-dose pharmacokinetics of PPA in 10 healthy volunteers taking controlled release suspension (C) or tablet (T), each containing 150 mg PPA was compared. The study described here has shown that the (C) AUC(0-infinity)/(T) AUC(0-infinity) = 1.02 (P greater than 0.4). The controlled-release product of PPA is equivalent to PPA tablet.

摘要

本文介绍了人血浆中苯丙醇胺(PPA)的高效液相色谱分析方法。采用直接紫外检测法,该方法对PPA的检测灵敏度足以达到25 ng/ml。比较了10名健康志愿者服用控释混悬液(C)或片剂(T)(均含150 mg PPA)后PPA的单剂量药代动力学。此处描述的研究表明,(C)的AUC(0-无穷大)/(T)的AUC(0-无穷大)=1.02(P>0.4)。PPA的控释产品与PPA片剂等效。

相似文献

1
[Bioavailability of a controlled-release suspension of phenylpropanolamine in healthy volunteers].[苯丙醇胺控释混悬液在健康志愿者中的生物利用度]
Yao Xue Xue Bao. 1992;27(4):299-302.
2
[Comparison of multiple dosage bioavailability between phenylpropanolamine controlled release suspension and conventional tablet in healthy volunteers].苯丙醇胺控释混悬液与普通片剂在健康志愿者体内的多剂量生物利用度比较
Yao Xue Xue Bao. 1995;30(2):157-60.
3
Relative bioavailability of carbinoxamine and phenylpropanolamine from a retard suspension after single dose administration in healthy subjects.健康受试者单剂量服用后,卡比沙明和苯丙醇胺从缓释混悬液中的相对生物利用度。
Arzneimittelforschung. 1992 Dec;42(12):1478-81.
4
In-vivo pharmacokinetic characteristics of a transdermal phenylpropanolamine (PPA) preparation.一种苯丙醇胺(PPA)透皮制剂的体内药代动力学特征。
Eur J Drug Metab Pharmacokinet. 1991;Spec No 3:297-9.
5
Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.400毫克阿昔洛韦的两种口服混悬剂和两种口服片剂剂型的生物利用度:在健康墨西哥成年受试者中进行的两项单剂量、开放标签、随机、两期交叉比较。
Clin Ther. 2007 Jun;29(6):1146-52. doi: 10.1016/j.clinthera.2007.06.007.
6
Phenylpropanolamine pharmacokinetics in dogs after intravenous, oral, and oral controlled-release doses.犬静脉注射、口服及口服控释剂量后苯丙醇胺的药代动力学
Biopharm Drug Dispos. 1987 Sep-Oct;8(5):497-505. doi: 10.1002/bdd.2510080509.
7
[Pharmacokinetics and relative bioavailability of KC-404 sustained release tablets in healthy volunteers].KC-404缓释片在健康志愿者体内的药代动力学及相对生物利用度
Sichuan Da Xue Xue Bao Yi Xue Ban. 2003 Jul;34(3):541-3.
8
Bioavailability and cardiovascular safety of Dexatrim (phenylpropanolamine hydrochloride) from a controlled-release caplet.控释胶囊剂中Dexatrim(盐酸苯丙醇胺)的生物利用度及心血管安全性
Biopharm Drug Dispos. 1990 Oct;11(7):569-83. doi: 10.1002/bdd.2510110703.
9
Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.芬太尼泡腾颊片(FEBT)1080微克与口腔黏膜枸橼酸芬太尼1600微克的相对生物利用度以及FEBT 270至1300微克的剂量比例:一项在健康成年志愿者中进行的单剂量、随机、开放标签、三周期研究。
Clin Ther. 2006 May;28(5):715-24. doi: 10.1016/j.clinthera.2006.05.016.
10
Bioavailability and bioequivalence of two oral formulations of alendronate sodium 70 mg: an open-label, randomized, two-period crossover comparison in healthy Korean adult male volunteers.70毫克阿仑膦酸钠两种口服制剂的生物利用度和生物等效性:在健康韩国成年男性志愿者中进行的开放标签、随机、两周期交叉比较。
Clin Ther. 2009 May;31(5):1037-45. doi: 10.1016/j.clinthera.2009.05.001.